Higher Dose of Fulvestrant Associated With Improved Survival in Advanced Breast Cancer

Article

Postmenopausal women with advanced estrogen receptor–positive breast cancer lived longer when they received a 500-mg dose of fulvestrant as compared with a 250-mg dose.

Postmenopausal women with advanced estrogen receptor–positive breast cancer lived longer when they received a 500-mg dose of fulvestrant as compared with a 250-mg dose.

Click here to view this article.

Related Videos
Payal Kohli, MD | Credit: Cherry Creek Heart
Video 2 - "Stricter LDL-C Targets: Explaining Goalpost Changes to Patients"
Video 1 - "Overview of Low-Density Lipoprotein Cholesterol Management"
Thumbnail featuring Jay Luther, MD, Hersh Shroff, MD, MPA, and Chris Kahler, PhD
Thumbnail featuring Jay Luther, MD, Hersh Shroff, MD, MPA, and Chris Kahler, PhD
Related Content
RA Significantly Impairs Physical, Psychosocial Functioning

RA Significantly Impairs Physical, Psychosocial Functioning

May 4th 2024
Article
Exploring Procedural Treatments for Dry Eye

Exploring Procedural Treatments for Dry Eye

May 2nd 2024
Podcast
Central Centrifugal Cicatricial Alopecia: Perceptions of Severity Among Black Female Patients

Central Centrifugal Cicatricial Alopecia: Perceptions of Severity Among Black Female Patients

May 3rd 2024
Article
2024 State of the Air: Record Highs in US Particle Pollution, with Dr. John Balmes

2024 State of the Air: Record Highs in US Particle Pollution, with John Balmes, MD

April 24th 2024
Podcast
Yanzheng Zou | Credit: ResearchGate

Acute Hepatitis C, HCV-Related Cirrhosis on the Rise in Reproductive Age Women

May 3rd 2024
Article
Mediterranean Diet Improves Pain, QoL in Patients with Fibromyalgia

Mediterranean Diet Improves Pain, QoL in Patients with Fibromyalgia

May 3rd 2024
Article
© 2024 MJH Life Sciences

All rights reserved.